Methylhexanamine
Also known as 4-methylhexan-2-amine, methylhexamine, 1,3-dimethylamylamine, dimethylamylamine
Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.IUPAC_name
- 4-Methylhexan-2-amine
- Drug.image
- Geranamine.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Geranamine-3D-balls.png
- Drug.image_class2
- bg-transparent
- Drug.legal_AU
- S10
- Drug.legal_BR
- F2
- Drug.legal_US
- Unapproved drug; use in dietary supplements, food, or medicine is unlawful.
- Drug.routes_of_administration
- Nasal spray, oral
- Drug.elimination_half life
- ~8.5 hours
Gallery (2)
Connections
Categories
AlkylaminesBodybuilding supplementsChemical pages without DrugBank identifierDecongestantsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by Eli Lilly and CompanyDrugs not assigned an ATC codeDrugs with non-standard legal statusECHA InfoCard ID from WikidataHepatotoxinsNorepinephrine-dopamine releasing agents